ZYUS Life Sciences
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
204-407 Downey Rd, Saskatoon, Saskatchew...Phone Number
(306) 242-2357Website
www.zyus.comRevenue
$17.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About ZYUS Life Sciences
ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. Through clinical research and IP development, the company intend to deliver high-quality oils, softgels, topical creams and other cannabinoid-based therapeutics and product candidates to patients worldwide. The ZYUS vision is to elevate cannabinoids as a standard of care and expand the potential of protein-based formulations in pursuit of a transformational impact on patients' lives. ZYUS: Advancing the Science of Well-Being.Explore more
ZYUS Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ZYUS Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ZYUS Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if ZYUS Life Sciences had a recent Job posting/layoffs
Check if ZYUS Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when ZYUS Life Sciences launches new products
Congratulate Masked Content for being promoted to Masked Content at ZYUS Life Sciences
Funding: Get notified immidiatlly once ZYUS Life Sciences has new funding data
Check out if ZYUS Life Sciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on ZYUS Life Sciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined ZYUS Life Sciences as Masked Content
Find 3 more new buyers
Compare Similar Companies to ZYUS Life Sciences
Compare insights from companies similar to ZYUS Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$11.8M
51-200
Private
-
2014
WN
Wilkinson NarcisseDirector, Clinical Trial Operation & Chief Revenue Officer, Unit
Company Profile Activity
Activity Insights
ZYUS Life Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ZYUS Life Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ZYUS Life Sciences.
ZYUS Life Sciences financials insights
Gather financial insights about ZYUS Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$73K
ZYUS Life Sciences Tech Stack
A closer look at the technologies used by ZYUS Life Sciences
See more technologies
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
ZYUS Life Sciences News & Media
ZYUS Life Sciences Corporation Announces Closing of Second Tranche of Secured Loan ...
/CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of...ZYUS Life Sciences Corporation Announces Closing of First Tranche of Secured Loan ...
ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, is pleased to announce that its wholly-owned subsidiary, ZYUS Life Sciences Inc. ("ZYUS Inc."), has closed a first tranche (the "First Tranche") of a secured loan financing (the "SecuredLoan") on May 20, 2026 with certain lenders (the "Lenders"), including certain insiders of the Company, forZYUS Life Sciences Expands U.S. Patent Portfolio with Second Pain Management Patent
Issuance of U.S. patent supports ongoing clinical research in chronic and neuropathic pain SASKATOON, SK, May 5, 2026 /PRNewswire/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of...ZYUS Life Sciences Provides an Update on Its Unit Offering - Newswire.ca
/CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical stage life sciences company focused on the development and commercialization of...
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ZYUS Life Sciences
Sign Up For FreeTo access detailed company insights
ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. Through clinical research and IP development, the company intend to deliver high-quality oils, softgels, topical creams and other cannabinoid-based therapeutics and product candi... Read More
